Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Capitol Hill

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

News Analysis

DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated

Guest Editorial

Rathmell: We must support our junior colleagues
“Empathy and listening is a key place to start”

Guest Editorial

Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunity
Weill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration

In Brief

Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy

Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Beverly Ginsburg Cooper honored with ACCA Career Achievement award

Jeffrey Lee named chief medical executive at MD Anderson

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

Drugs & Targets

FDA approves cabozantinib for patients 12 and up with pNET and epNET

FDA approves prostate cancer imaging agent Gozellix

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

EC expands approval for Breyanzi for r/r follicular lymphoma

EC approves Opdivo + Yervoy as first-line treatment for HCC

China’s National Medical Products Administration grants Breakthrough Therapy designation to olverembatinib for Ph+ ALL

In The Clinic

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Free Trials & Tribulations

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Trials & Tribulations

LLS former CSO: Immunotherapy, precision medicine redefined blood cancer treatment

Trials & Tribulations

Physicians and biopharma should improve accessibility of cancer trials

Trials & Tribulations

From clinician scientist to nonprofit CEO

Latest Issue

Read the latest issue

DOWNLOAD THE PDF

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Apr 2025

Miami Leukemia Symposium

Cellicon Valley ’25: The Future of Cell and Gene Therapies

May 2025

NCCN Oncology Policy Summit: Primary Care and Oncology Collaboration to Improve Patient Outcomes

2025 AAADV Workshop

2025 ASCO Annual Meeting

View All Events

Conversations with The Cancer Letter

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

RWD company documents baseline trends in women’s cancers before Trump’s policy changes

After 25 years as FDA’s chief cancer strategist, Richard Pazdur reflects on opportunities for change at the agency

Contributors

Edward S. Kim, MD, MBA

Building a nationally integrated cancer research and treatment network

Shannon McWeeney, PhD

Caught in the crossfire: The critical threats facing cancer centers, research, and patient care

W. Kimryn Rathmell, MD, PhD, MMHC

Rathmell: We need a “March Madness” for cancer research
“Cancer is a tremendously challenging tournament, but we are in it to win”

Jamillah Hoy-Rosas, MPH, RD, CDCES

Health innovation and health equity: Ensuring technologies advance resilience, justice, and compassionate care

Trending Stories

DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated
Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology
What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”
Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills
Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

Recent Issues

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology

DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated

Rathmell: We must support our junior colleagues
“Empathy and listening is a key place to start”

Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunity
Weill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration

Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy

Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer

Karen Knudsen joins Paradigm Health’s board of directors as company prepares launch of AI-driven clinical trial data collection and management application

Beverly Ginsburg Cooper honored with ACCA Career Achievement award

Jeffrey Lee named chief medical executive at MD Anderson

Michael Chan named chair of Wake Forest’s Department of Radiation Oncology

FDA approves cabozantinib for patients 12 and up with pNET and epNET

FDA approves prostate cancer imaging agent Gozellix

FDA approves Keytruda combination for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)

EC expands approval for Breyanzi for r/r follicular lymphoma

EC approves Opdivo + Yervoy as first-line treatment for HCC

China’s National Medical Products Administration grants Breakthrough Therapy designation to olverembatinib for Ph+ ALL

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

LLS former CSO: Immunotherapy, precision medicine redefined blood cancer treatment

Physicians and biopharma should improve accessibility of cancer trials

From clinician scientist to nonprofit CEO

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

RWD company documents baseline trends in women’s cancers before Trump’s policy changes

After 25 years as FDA’s chief cancer strategist, Richard Pazdur reflects on opportunities for change at the agency

Edward S. Kim, MD, MBA

Shannon McWeeney, PhD

W. Kimryn Rathmell, MD, PhD, MMHC

Jamillah Hoy-Rosas, MPH, RD, CDCES

Never miss an issue!

Login

Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

Shearwood McClelland III: “When you stand for something, you’re always going to be attacked.”

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America“It gives America, in part, its identity.”

RWD company documents baseline trends in women’s cancers before Trump’s policy changes

After 25 years as FDA’s chief cancer strategist, Richard Pazdur reflects on opportunities for change at the agency

Never miss an issue!

Login

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”